Solentim, a global leader in cell line development instrumentation, will be attending and exhibiting at BPI Europe, 2-5 April, in Vienna, Austria. Experts from the Company will be on hand throughout the event at the Solentim exhibition booth (#83) to discuss our latest innovations and to answer any questions. Also speaking at the event will …
When developing biotherapeutics there are many parts of the process that require optimisation. Cell line development is a key part of this process and there are many aspects where changes can have a dramatic effect on timelines and outcomes. One key area which is challenging to many of our customers is outgrowth of clones in …
Solentim, a global leader in cell line development instrumentation, will be attending IMAPAC’s Biologics World Nordic event, 5-7 March in Stockholm. Experts from the Company will be on hand throughout the event at the Solentim exhibition booth (number 2) to discuss our latest innovations and to answer any questions. The global biologic medicines market is …
Read more Connect with Solentim at IMAPAC: Biologics World Nordic 2019
Solentim is delighted to announce it will be speaking and exhibiting at BioProcess International Asia (BPI Asia), taking place 27-28th February in Tokyo, Japan. BPI Asia is a truly international event, with global leaders from across Asia, USA and Europe sharing their knowledge and expertise on how to drive down costs, shorten timelines, and navigate the regulatory …
Read more Solentim to present and exhibit at BioProcess International Asia
21st February 2019: Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announced a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines. Valitacell’s novel in-line analytical profiling technologies and its data-driven/machine learning approach, together with Solentim’s …
NEWS – Bournemouth, 11th February 2019: Solentim, a global leader in cell line development instrumentation, is pleased to announce they will be attending the ELRIG CRISPR in Drug Discovery 2019: From Targets to Therapeutics meeting on the 27-28 February, Oxford, UK. The meeting will focus on the application of genome engineering to identify novel drug targets through …
